Despite Disinformation Attempt, Antitrust Case Against IQVIA Moves Forward and Report of FTC Investigation of IQVIA Comes to Light

Despite Disinformation Attempt, Antitrust Case Against IQVIA Moves Forward and Report of FTC Investigation of IQVIA Comes to Light
IQVIA continues unethical tactics to divert attention from industry-wide issue: IQVIA monopoly abuse harms life sciences companies and patients
News provided by
Share this article
Share this article
PLEASANTON, Calif., May 11, 2021 /PRNewswire/ -- Consistent with its history of deceptive and unethical behavior, IQVIA (NYSE: IQV) yesterday issued a press release that mischaracterizes the nature of a recent procedural e-discovery ruling in Veeva Systems (NYSE: VEEV) antitrust case against IQVIA.
The release is another IQVIA attempt to divert attention from the core issue — IQVIA's unlawful tactics to retain monopoly control of data crucial to the life sciences industry and use that position to extend its monopoly into the software market.

Related Keywords

Deivis Mercado ,Josh Faddis ,Capitol Forum ,A Public Benefit Corporation ,Veeva Systems ,Withholding Data ,Federal Trade Commission ,Dispute Relates ,Isolated Data Leak ,Public Benefit Corporation ,Financial Condition ,ஜோஷ் படடிச் ,கேபிடல் மன்றம் ,கூட்டாட்சியின் வர்த்தகம் தரகு ,பொது நன்மை நிறுவனம் ,நிதி நிலை ,